These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32441479)

  • 41. Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003-2008).
    Marconato L; Romanelli G; Stefanello D; Giacoboni C; Bonfanti U; Bettini G; Finotello R; Verganti S; Valenti P; Ciaramella L; Zini E
    J Am Vet Med Assoc; 2009 Oct; 235(8):967-72. PubMed ID: 19827983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and pathological prognostic factors in canine mammary tumors.
    Pérez Alenza MD; Peña L; Nieto AI; Castaño M
    Ann Ist Super Sanita; 1997; 33(4):581-5. PubMed ID: 9616968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.
    Ray S; Ray A
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010338. PubMed ID: 25426776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nuclear morphometry in relation to lymph node status in canine mammary carcinomas.
    De Vico G; Maiolino P; Cataldi M; Mazzullo G; Restucci B
    Vet Res Commun; 2007 Nov; 31(8):1005-11. PubMed ID: 17279466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative pathology of canine mammary tumours.
    Nerurkar VR; Chitale AR; Jalnapurkar BV; Naik SN; Lalitha VS
    J Comp Pathol; 1989 Nov; 101(4):389-97. PubMed ID: 2558128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
    Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
    Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retrospective evaluation of a modified human lung cancer stage classification in dogs with surgically excised primary pulmonary carcinomas.
    Lee BM; Clarke D; Watson M; Laver T
    Vet Comp Oncol; 2020 Dec; 18(4):590-598. PubMed ID: 32115867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tolerability and pharmacokinetic profile of a novel benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride in dogs with malignant mammary tumours.
    Kristiansen VM; Dewi S; Horsberg TE; Jonasdottir TJ; Moe L; Berlinger B; Lindkaer-Jensen S; Larsen S
    Vet Comp Oncol; 2017 Mar; 15(1):118-132. PubMed ID: 25764447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. One-year conditional survival of dogs and cats with invasive mammary carcinomas: A concept inspired from human breast cancer.
    Chocteau F; Mordelet V; Dagher E; Loussouarn D; Abadie J; Nguyen F
    Vet Comp Oncol; 2021 Mar; 19(1):140-151. PubMed ID: 32954630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma.
    Stockhaus C; Kohn B; Rudolph R; Brunnberg L; Giger U
    J Small Anim Pract; 1999 Jul; 40(7):326-31. PubMed ID: 10444752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of tamoxifen in the control of canine mammary neoplasia.
    Morris JS; Dobson JM; Bostock DE
    Vet Rec; 1993 Nov; 133(22):539-42. PubMed ID: 8116156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
    Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Canine mammary gland tumors.
    Sorenmo K
    Vet Clin North Am Small Anim Pract; 2003 May; 33(3):573-96. PubMed ID: 12852237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas.
    Guil-Luna S; Sánchez-Céspedes R; Millán Y; De Andrés FJ; Rollón E; Domingo V; Guscetti F; Martín de Las Mulas J
    J Vet Intern Med; 2011; 25(3):518-23. PubMed ID: 21488964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival.
    Araújo MR; Campos LC; Damasceno KA; Gamba CO; Ferreira E; Cassali GD
    Res Vet Sci; 2016 Jun; 106():121-30. PubMed ID: 27234549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
    Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
    J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma.
    Rossi F; Sabattini S; Vascellari M; Marconato L
    Vet Comp Oncol; 2018 Dec; 16(4):497-504. PubMed ID: 29806156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does desmopressin reduce bleeding in liver surgery? An experimental study on pigs.
    Walther C; Hermansson M; Zilling T
    In Vivo; 1999; 13(1):83-5. PubMed ID: 10218138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method.
    Karayannopoulou M; Kaldrymidou E; Constantinidis TC; Dessiris A
    J Comp Pathol; 2005 Nov; 133(4):246-52. PubMed ID: 16202421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of endothelin-1 and endothelin-1 receptor A in canine mammary tumours.
    Restucci B; Martano M; Maiolino P
    Res Vet Sci; 2015 Jun; 100():182-8. PubMed ID: 25816929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.